Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
patent 6,288,079 1 2 European Journal of Pharmacology
Studies have suggested a 15-18% reduction in visceral fat over 26 weeks with moderate IGF-1 elevation
Hops extract stimulates satiety for faster appetite control and helps decrease insulin resistance and balance blood glucose levels.*
Researchers who have never used a GLP-1 agonist should generally start with tirzepatide or even semaglutide to understand their individual response to incretin therapy before attempting a triple agonist with higher side effect rates
Pogrel MA
10.1073/pnas.2506321122 32 TaoZ.Le Blanc JustinM.WangC.ZhanT.ZhuangH.WangP.et al (2016)
US$ 25.70
US$ 28.73
US$ 22.26
US$ 27.67
US$ 24.56
US$ 27.07
US$ 25.94
